While awaiting an FDA decision for its small molecule revumenib in one form of acute leukemia, Syndax Pharmaceuticals is ...
Read more about A study looking at an intestinal microbiota transplant before a donor stem cell transplant for blood cancer (MAST) A trial of magrolimab with chemotherapy to treat acute myeloid ...
Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML patients to reveal resistance mechanisms to the Bcl-2 inhibitor venetoclax and ...
Study methods and results In this study, the researchers compared genetic mutation frequencies of 100 Black patients with AML to those of 323 white patients with AML and found that 73% of 162 gene ...
When resistance to or failure of hypomethylating agents (HMAs) occurs in acute myeloid leukemia (AML), depleting a ligase ...
The technology accurately detects the presence of these gene fusions in acute promyelocytic ... Is Linked to Childhood Leukemia Sep. 30, 2024 — A study of more than 700 counties across multiple ...
Acute lymphoblastic leukemia/lymphoma (ALL), also called acute lymphocytic ... This is why we do clinical trials (also called clinical studies). Through these studies, we are able to offer you ...
More information: Ali Bazarbachi et al, Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute ...
Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer. Some people live a long time with CMML, but others go on to develop acute myeloid leukemia ... States, 1 to 2 people in ...
Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.
Cortes, the director of the Georgia Cancer Center at Augusta University, said that Scemblix had the ability to change the ...
A new study reveals a modular CAR-T approach that effectively targets heterogeneous antigens in paediatric acute myeloid leukaemia, enhancing treatment success through combinatorial targeting.